AzTrials
AzTrials

Obesity, MorbidNCT06338969

The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis

A study testing Carbohydrate Restriction after a Gastric Bypass in people with Obesity, Morbid and NASH, run by The Society of Bariatric and Metabolic Surgeons of Kazakhstan at 1 site in Kazakhstan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: Ketosis after bariatric surgery is a metabolic process that occurs when the body breaks down fat for energy because of not getting enough carbohydrates. Insufficient production of ketone bodies reduces the rate of weight loss, and excessive amounts of ketones can lead to ketoacidosis or liver failure in… Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Obesity, Morbid, NASH, Ketosis
What is being tested?
Carbohydrate Restriction after a Gastric Bypass
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteKazakhstan
Study dates
25 Mar 2024to 1 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • obesity patients BMI 30-50 kg/m2.
  • patients with nonalcoholic steatohepatitis (NASH).

Who cannot join

  • patients with active physical sports
  • diabetes
  • cirrhosis

Trial locations and contacts

1 site in 1 country.

Kazakhstan1 site, 1 recruiting
  • Oral Ospanov

    Astana, Aqmola, 010000

    Oral Ospanov, PhD, 7015287734 ext. +7, bariatric.kz@gmail.com

    Recruiting

Other trials in Kazakhstan

About this study

Official title: The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Manifestation of Starvation Ketosis and Ketoacidosis in Patients With Nonalcoholic Steatohepatitis

Background:

Ketosis after bariatric surgery is a metabolic process that occurs when the body breaks down fat for energy because of not getting enough carbohydrates.

Read more

Insufficient production of ketone bodies reduces the rate of weight loss, and excessive amounts of ketones can lead to ketoacidosis or liver failure in patients with nonalcoholic steatohepatitis (NASH).

The investigators hypothesize that weight loss is directly related to calorie intake, and a significant reduction in carbohydrate content leads to increased ketosis and the risk of ketoacidosis.

Objectives:

The study aimed to compare the incidence of ketoacidosis and liver failure in patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass. In addition, the investigators want to find out how carbohydrate restriction will affect weight loss for up to 1 year.

Read the detailed description

Methods:

This study is a three-arm randomized controlled trial. All patients will undergo laparoscopic one anastomotic gastric bypass. In the postoperative period, all patients will receive normal daily amounts of protein and fat. Depending on the amount of carbohydrates that will be received after surgery, patients will randomly (no mask) be divided into three groups:

The first group: 51-75% deficit in carbohydrates Second group: 26-50% deficit in carbohydrates The third group: has a 1-25% deficit in carbohydrates.

Primary outcome measurement Compare the incidence of ketoacidosis and liver failure in three groups of patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass.

Secondary outcome measurements Change in body mass index (Δ BMI). Effect weight loss for up to 1 year.

Being tested
Carbohydrate Restriction after a Gastric Bypass
Keywords
Carbohydrate restriction, Ketosis after bariatric surgery
Medical subject headings
Obesity, Morbid, Ketosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Carbohydrate Restriction after a Gastric BypassOther

    Also called laparoscopic one anastomotic gastric bypass

    All patients will undergo laparoscopic one anastomotic gastric bypass. In the postoperative period, all patients will receive normal daily amounts of protein and fat. Depending on the amount of carbohydrates that will be received after surgery, patients will randomly (no mask) be divided into three groups:

    The first group: 51-75% deficit in carbohydrates Second group: 26-50% deficit in carbohydrates The third group: has a 1-25% deficit in carbohydrates.

Study groups in NCT06338969
Study groupRoleWhat they receive
Carbohydrate Restriction after a Gastric Bypass: 51-75% deficit in carbohydratesExperimentalIn the postoperative period, the amount of carbohydrate intake was reduced by counting carbohydrates in a glucose solution in the first three days after surgery and counting carbohydrates in food. Created a carbohydrate deficit of 51-75%.
Receives: Other: Carbohydrate Restriction after a Gastric Bypass
Carbohydrate Restriction after a Gastric Bypass: 26-50% deficit in carbohydratesActive comparatorIn the postoperative period, the amount of carbohydrate intake was reduced by counting carbohydrates in a glucose solution in the first three days after surgery and counting carbohydrates in food. Created a carbohydrate deficit: 26-50% deficit in carbohydrates.
Receives: Other: Carbohydrate Restriction after a Gastric Bypass
Carbohydrate Restriction after a Gastric Bypass:1-25% deficit in carbohydratesActive comparatorIn the postoperative period, the amount of carbohydrate intake was reduced by counting carbohydrates in a glucose solution in the first three days after surgery and counting carbohydrates in food. Created a carbohydrate deficit:1-25% deficit in carbohydrates.
Receives: Other: Carbohydrate Restriction after a Gastric Bypass

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cases of ketosis and incidence of ketoacidosis

    Compare the incidence of ketoacidosis and liver failure in three groups of patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass

    Measured: The time frame is baseline, first 7 days, 1, 3, 6,12 months after surgery.

  2. Cases of liver failure

    Compare the incidence of liver failure in three groups of patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass

    Measured: The time frame is baseline, first 7 days, 1, 3, 6,12 months after surgery.

Secondary outcomes (1)
  1. Change in body mass index (Δ BMI)

    This measurement assesses the change in BMI after the intervention. Weight (kg) and height (cm) will be combined in the BMI (kg/m2).

    Measured: The time frame is baseline,1, 3, 6,12 months after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2024
  2. Study start25 Mar 2024
  3. Primary completion1 Apr 2025 (estimated)
  4. Study completion1 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06338969
Sponsor's protocol ID
PostBariKetosis
Status last verified
Apr 2024
First submitted
24 Mar 2024
Last updated
3 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Carbohydrate Restriction after a Gastric Bypass in people with Obesity, Morbid and NASH, run by The Society of Bariatric and Metabolic Surgeons of Kazakhstan at 1 site in Kazakhstan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Kazakhstan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Oral Ospanov, PhD (7015287734 ext. +7, bariatric.kz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cases of ketosis and incidence of ketoacidosis (time frame: The time frame is baseline, first 7 days, 1, 3, 6,12 months after surgery.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in